drugset
drugset / Trial / NCT01233830

Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers

NCT01233830 ↗

Phase 1 Completed 19 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to assess safety, tolerability and pharmacokinetics of AZD2423 in young and elderly healthy Japanese volunteers.

Timeline

Start
2010-11
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD2423 Unknown — Oral

Indications

No indication recorded.